Anupam Rasayan India Limited (ANURAS) - Net Assets
Based on the latest financial reports, Anupam Rasayan India Limited (ANURAS) has net assets worth Rs34.49 Billion INR (≈ $373.01 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs56.50 Billion ≈ $611.01 Million USD) and total liabilities (Rs22.01 Billion ≈ $238.00 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Anupam Rasayan India Limited to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs34.49 Billion |
| % of Total Assets | 61.05% |
| Annual Growth Rate | 36.91% |
| 5-Year Change | 95.86% |
| 10-Year Change | N/A |
| Growth Volatility | 51.76 |
Anupam Rasayan India Limited - Net Assets Trend (2017–2025)
This chart illustrates how Anupam Rasayan India Limited's net assets have evolved over time, based on quarterly financial data. Also explore ANURAS asset base for the complete picture of this company's asset base.
Annual Net Assets for Anupam Rasayan India Limited (2017–2025)
The table below shows the annual net assets of Anupam Rasayan India Limited from 2017 to 2025. For live valuation and market cap data, see Anupam Rasayan India Limited market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | Rs30.82 Billion ≈ $333.27 Million |
+5.15% |
| 2024-03-31 | Rs29.31 Billion ≈ $316.94 Million |
+16.85% |
| 2023-03-31 | Rs25.08 Billion ≈ $271.24 Million |
+45.24% |
| 2022-03-31 | Rs17.27 Billion ≈ $186.75 Million |
+9.75% |
| 2021-03-31 | Rs15.73 Billion ≈ $170.16 Million |
+165.01% |
| 2020-03-31 | Rs5.94 Billion ≈ $64.21 Million |
+17.08% |
| 2019-03-31 | Rs5.07 Billion ≈ $54.84 Million |
+10.81% |
| 2018-03-31 | Rs4.58 Billion ≈ $49.49 Million |
+83.31% |
| 2017-03-31 | Rs2.50 Billion ≈ $27.00 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Anupam Rasayan India Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 531.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs8.34 Billion | 29.28% |
| Common Stock | Rs1.10 Billion | 3.86% |
| Other Comprehensive Income | Rs941.60 Million | 3.30% |
| Other Components | Rs18.12 Billion | 63.56% |
| Total Equity | Rs28.50 Billion | 100.00% |
Anupam Rasayan India Limited Competitors by Market Cap
The table below lists competitors of Anupam Rasayan India Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Almonty Industries Inc. Common Shares
NASDAQ:ALM
|
$1.65 Billion |
|
Cosmo Pharmaceuticals N.V
F:C43
|
$1.65 Billion |
|
Eco World Develop Group
KLSE:8206
|
$1.66 Billion |
|
PT Arkora Hydro Tbk
JK:ARKO
|
$1.66 Billion |
|
Greif Bros Corporation
NYSE:GEF
|
$1.65 Billion |
|
PLUXEE NV
PA:PLX
|
$1.65 Billion |
|
JiangXi Tianxin Pharm Co Ltd
SHG:603235
|
$1.65 Billion |
|
Global Partners LP
NYSE:GLP
|
$1.65 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Anupam Rasayan India Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 27,610,240,000 to 28,503,130,000, a change of 892,890,000 (3.2%).
- Net income of 933,490,000 contributed positively to equity growth.
- Dividend payments of 134,190,000 reduced retained earnings.
- New share issuances of 31,520,000 increased equity.
- Other comprehensive income decreased equity by 11,140,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs933.49 Million | +3.28% |
| Dividends Paid | Rs134.19 Million | -0.47% |
| Share Issuances | Rs31.52 Million | +0.11% |
| Other Comprehensive Income | Rs-11.14 Million | -0.04% |
| Other Changes | Rs73.21 Million | +0.26% |
| Total Change | Rs- | 3.23% |
Book Value vs Market Value Analysis
This analysis compares Anupam Rasayan India Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.18x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 26.91x to 5.18x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-03-31 | Rs49.93 | Rs1343.80 | x |
| 2018-03-31 | Rs72.99 | Rs1343.80 | x |
| 2019-03-31 | Rs67.95 | Rs1343.80 | x |
| 2020-03-31 | Rs77.77 | Rs1343.80 | x |
| 2021-03-31 | Rs191.51 | Rs1343.80 | x |
| 2022-03-31 | Rs172.23 | Rs1343.80 | x |
| 2023-03-31 | Rs228.22 | Rs1343.80 | x |
| 2024-03-31 | Rs254.94 | Rs1343.80 | x |
| 2025-03-31 | Rs259.45 | Rs1343.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Anupam Rasayan India Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.28%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.47%
- • Asset Turnover: 0.27x
- • Equity Multiplier: 1.85x
- Recent ROE (3.28%) is below the historical average (7.83%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 13.94% | 12.26% | 0.45x | 2.53x | Rs98.24 Million |
| 2018 | 9.03% | 11.91% | 0.35x | 2.19x | Rs-44.57 Million |
| 2019 | 9.71% | 9.61% | 0.39x | 2.61x | Rs-14.63 Million |
| 2020 | 8.96% | 9.93% | 0.32x | 2.80x | Rs-61.66 Million |
| 2021 | 4.47% | 8.61% | 0.36x | 1.46x | Rs-870.44 Million |
| 2022 | 8.81% | 14.17% | 0.37x | 1.67x | Rs-205.06 Million |
| 2023 | 7.62% | 11.29% | 0.42x | 1.59x | Rs-564.14 Million |
| 2024 | 4.66% | 8.69% | 0.32x | 1.67x | Rs-1.47 Billion |
| 2025 | 3.28% | 6.47% | 0.27x | 1.85x | Rs-1.92 Billion |
Industry Comparison
This section compares Anupam Rasayan India Limited's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $5,892,160,034
- Average return on equity (ROE) among peers: 15.44%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Anupam Rasayan India Limited (ANURAS) | Rs34.49 Billion | 13.94% | 0.64x | $1.65 Billion |
| Aarti Industries Limited (AARTIIND) | $16.55 Billion | 20.11% | 1.65x | $1.99 Billion |
| Aarti Surfactants Limited (AARTISURF) | $1.11 Billion | 1.88% | 1.36x | $37.34 Million |
| ABM International Limited (ABMINTLLTD) | $161.33 Million | 4.08% | 2.02x | $4.23 Million |
| Advanced Enzyme Technologies Limited (ADVENZYMES) | $1.66 Billion | 30.02% | 1.39x | $420.87 Million |
| Aether Industries Limited (AETHER) | $22.26 Billion | 7.12% | 0.19x | $1.68 Billion |
| Akzo Nobel India Limited (AKZOINDIA) | $9.20 Billion | 20.25% | 0.96x | $1.45 Billion |
| Alkali Metals Limited (ALKALI) | $528.67 Million | 5.51% | 1.00x | $7.38 Million |
| Alkyl Amines Chemicals Limited (ALKYLAMINE) | $980.47 Million | 17.95% | 1.88x | $838.56 Million |
| Ami Organics Limited (AMIORG) | $576.82 Million | 32.06% | 1.70x | $1.18 Billion |
About Anupam Rasayan India Limited
Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients … Read more